CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquires Blue Stream Laboratories
Snapshot
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired Blue Stream Laboratories for $11.7 million (including $3.0 million in contingent consideration) in January 2016. The transaction was structured as all cash. Blue Stream Laboratories is a United States-based Discovery and Safety Assessment (DSA) business.
- Acquirer
- CHARLES RIVER LABORATORIES INTERNATIONAL, INC.
- Target
- Blue Stream Laboratories
- Value
- $11.7 million (including $3.0 million in contingent consideration)
- Date
- January 2016
- Type
- full acquisition
- Status
- ready
The deal at a glance
About this deal
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. acquired Blue Stream Laboratories for $11.7 million (including $3.0 million in contingent consideration), a transaction completed in January 2016, structured as all cash.
Blue Stream Laboratories operates in Discovery and Safety Assessment (DSA), is based in United States. Blue Stream Laboratories was an analytical CRO supporting the development of complex biologics and biosimilars.
Combining Blue Stream with our existing discovery, safety assessment, and biologics capabilities creates a leading provider with the ability to support biologic and biosimilar development from characterization through clinical testing and commercialization. The purchase price for Blue Stream was $11.7 million.
DSA segment, biologics analytical capabilities
No advisory firms have been disclosed for this transaction.